Selective Refueling of CAR T Cells Using ADA1 and CD26 Boosts Antitumor Immunity

Scientists presented a metabolic refueling approach using inosine as an alternative fuel. CAR T cells were engineered to express membrane-bound CD26 and cytoplasmic adenosine deaminase 1 (ADA1), converting adenosine to inosine.